Schedule 13D ownership disclosure

TENAX THERAPEUTICS INC

Security class unavailable · CUSIP: 88032L209

Event date: 2020-06-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001783976-20-000009
Form type
SC 13D/A
Filer
Binsalamah Ziyad
CIK
CIK 1783976
Filed
Jun 02, 2020
Reporting period
Jun 02, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub